Sign in
4

Changes in Ownership

4D Molecular Therapeutics, Inc. Filed Acc 0001193125-25-320992

Director acquired 9,333 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
THEUER CHARLES Director 2025-12-12 Option exercise +9,333 $1.14 $10,640 41,684 D
Derivatives
THEUER CHARLES Director 2025-12-12 Option exercise · Stock Option (Right to Buy) −9,333 0 D
Loading xslF345X05/ownership.xml…